Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

M. K. Ijaz, T. O. Alkarmi, A. W. El-Mekki, Sehamuddin Galadari, F. K. Dar, L. A. Babiuk

Research output: Contribution to journalArticle

Abstract

Synthetic peptides derived from bovine rotavirus C-486 (BRV) outer capsid (VP7 and VP4) and inner capsid (VP6) proteins were tested to evaluate their ability to prime and induce an anti-rotavirus antibody response. Peptides corresponding to the amino acid residues 232-255 of VP4 (VP4-peptide), 275-295 of VP7 (VP7-peptide) and 40-60 of VP6 (VP6-peptide) of BRV were chemically synthesized. These peptides were coupled to carrier proteins (either keyhole limpet haemocyanin (KLH) or recombinant rotavirus inner capsid protein-VP6 assembled into virus-like particles (VP6-carrier) were used as carrier to link the synthetic peptides under study), and the resulting conjugates were used to immunize rotavirus seronegative mice. An enzyme-linked immunosorbent assay (ELISA) was used to determine anti-peptide and anti-rotavirus antibody titres in serum samples collected after immunization. All peptides were immunogenic in mice and induced the production of anti-peptide antibodies, but with the exception of VP6-peptide they were not able to induce anti-rotavirus antibodies as measured by ELISA. Western blot analysis indicated that antibodies against each peptide were able to react with the respective authentic viral proteins of various rotavirus serotypes. To determine if a peptide-primed animal would respond to native viral proteins, animals were subsequently injected with purified BRV. A rapid and high anti-rotavirus antibody titre, in addition to a rise in anti-peptide antibody titre, was observed in peptide-primed mice. Furthermore, the sera obtained from these mice neutralized the virus under in vitro conditions. The significance of these results in relation to a potential rotavirus synthetic peptide-based vaccine is discussed.

Original languageEnglish (US)
Pages (from-to)331-338
Number of pages8
JournalVaccine
Volume13
Issue number4
DOIs
StatePublished - Jan 1 1995

Fingerprint

synthetic peptides
Rotavirus
Antibody Formation
Anti-Idiotypic Antibodies
peptides
Peptides
antibodies
Rotavirus C
viral proteins
mice
coat proteins
Capsid Proteins
Viral Proteins
cattle
enzyme-linked immunosorbent assay
Enzyme-Linked Immunosorbent Assay
virus-like particles
capsid
transport proteins
Synthetic Vaccines

Keywords

  • antibody response
  • Rotavirus
  • synthetic peptides

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4. / Ijaz, M. K.; Alkarmi, T. O.; El-Mekki, A. W.; Galadari, Sehamuddin; Dar, F. K.; Babiuk, L. A.

In: Vaccine, Vol. 13, No. 4, 01.01.1995, p. 331-338.

Research output: Contribution to journalArticle

Ijaz, M. K. ; Alkarmi, T. O. ; El-Mekki, A. W. ; Galadari, Sehamuddin ; Dar, F. K. ; Babiuk, L. A. / Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4. In: Vaccine. 1995 ; Vol. 13, No. 4. pp. 331-338.
@article{33a704e5a23f457596d7c7279a63014c,
title = "Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4",
abstract = "Synthetic peptides derived from bovine rotavirus C-486 (BRV) outer capsid (VP7 and VP4) and inner capsid (VP6) proteins were tested to evaluate their ability to prime and induce an anti-rotavirus antibody response. Peptides corresponding to the amino acid residues 232-255 of VP4 (VP4-peptide), 275-295 of VP7 (VP7-peptide) and 40-60 of VP6 (VP6-peptide) of BRV were chemically synthesized. These peptides were coupled to carrier proteins (either keyhole limpet haemocyanin (KLH) or recombinant rotavirus inner capsid protein-VP6 assembled into virus-like particles (VP6-carrier) were used as carrier to link the synthetic peptides under study), and the resulting conjugates were used to immunize rotavirus seronegative mice. An enzyme-linked immunosorbent assay (ELISA) was used to determine anti-peptide and anti-rotavirus antibody titres in serum samples collected after immunization. All peptides were immunogenic in mice and induced the production of anti-peptide antibodies, but with the exception of VP6-peptide they were not able to induce anti-rotavirus antibodies as measured by ELISA. Western blot analysis indicated that antibodies against each peptide were able to react with the respective authentic viral proteins of various rotavirus serotypes. To determine if a peptide-primed animal would respond to native viral proteins, animals were subsequently injected with purified BRV. A rapid and high anti-rotavirus antibody titre, in addition to a rise in anti-peptide antibody titre, was observed in peptide-primed mice. Furthermore, the sera obtained from these mice neutralized the virus under in vitro conditions. The significance of these results in relation to a potential rotavirus synthetic peptide-based vaccine is discussed.",
keywords = "antibody response, Rotavirus, synthetic peptides",
author = "Ijaz, {M. K.} and Alkarmi, {T. O.} and El-Mekki, {A. W.} and Sehamuddin Galadari and Dar, {F. K.} and Babiuk, {L. A.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0264-410X(95)98252-6",
language = "English (US)",
volume = "13",
pages = "331--338",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

AU - Ijaz, M. K.

AU - Alkarmi, T. O.

AU - El-Mekki, A. W.

AU - Galadari, Sehamuddin

AU - Dar, F. K.

AU - Babiuk, L. A.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Synthetic peptides derived from bovine rotavirus C-486 (BRV) outer capsid (VP7 and VP4) and inner capsid (VP6) proteins were tested to evaluate their ability to prime and induce an anti-rotavirus antibody response. Peptides corresponding to the amino acid residues 232-255 of VP4 (VP4-peptide), 275-295 of VP7 (VP7-peptide) and 40-60 of VP6 (VP6-peptide) of BRV were chemically synthesized. These peptides were coupled to carrier proteins (either keyhole limpet haemocyanin (KLH) or recombinant rotavirus inner capsid protein-VP6 assembled into virus-like particles (VP6-carrier) were used as carrier to link the synthetic peptides under study), and the resulting conjugates were used to immunize rotavirus seronegative mice. An enzyme-linked immunosorbent assay (ELISA) was used to determine anti-peptide and anti-rotavirus antibody titres in serum samples collected after immunization. All peptides were immunogenic in mice and induced the production of anti-peptide antibodies, but with the exception of VP6-peptide they were not able to induce anti-rotavirus antibodies as measured by ELISA. Western blot analysis indicated that antibodies against each peptide were able to react with the respective authentic viral proteins of various rotavirus serotypes. To determine if a peptide-primed animal would respond to native viral proteins, animals were subsequently injected with purified BRV. A rapid and high anti-rotavirus antibody titre, in addition to a rise in anti-peptide antibody titre, was observed in peptide-primed mice. Furthermore, the sera obtained from these mice neutralized the virus under in vitro conditions. The significance of these results in relation to a potential rotavirus synthetic peptide-based vaccine is discussed.

AB - Synthetic peptides derived from bovine rotavirus C-486 (BRV) outer capsid (VP7 and VP4) and inner capsid (VP6) proteins were tested to evaluate their ability to prime and induce an anti-rotavirus antibody response. Peptides corresponding to the amino acid residues 232-255 of VP4 (VP4-peptide), 275-295 of VP7 (VP7-peptide) and 40-60 of VP6 (VP6-peptide) of BRV were chemically synthesized. These peptides were coupled to carrier proteins (either keyhole limpet haemocyanin (KLH) or recombinant rotavirus inner capsid protein-VP6 assembled into virus-like particles (VP6-carrier) were used as carrier to link the synthetic peptides under study), and the resulting conjugates were used to immunize rotavirus seronegative mice. An enzyme-linked immunosorbent assay (ELISA) was used to determine anti-peptide and anti-rotavirus antibody titres in serum samples collected after immunization. All peptides were immunogenic in mice and induced the production of anti-peptide antibodies, but with the exception of VP6-peptide they were not able to induce anti-rotavirus antibodies as measured by ELISA. Western blot analysis indicated that antibodies against each peptide were able to react with the respective authentic viral proteins of various rotavirus serotypes. To determine if a peptide-primed animal would respond to native viral proteins, animals were subsequently injected with purified BRV. A rapid and high anti-rotavirus antibody titre, in addition to a rise in anti-peptide antibody titre, was observed in peptide-primed mice. Furthermore, the sera obtained from these mice neutralized the virus under in vitro conditions. The significance of these results in relation to a potential rotavirus synthetic peptide-based vaccine is discussed.

KW - antibody response

KW - Rotavirus

KW - synthetic peptides

UR - http://www.scopus.com/inward/record.url?scp=0028956654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028956654&partnerID=8YFLogxK

U2 - 10.1016/0264-410X(95)98252-6

DO - 10.1016/0264-410X(95)98252-6

M3 - Article

C2 - 7793126

AN - SCOPUS:0028956654

VL - 13

SP - 331

EP - 338

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 4

ER -